135 related articles for article (PubMed ID: 12866361)
1. Antimicrobial activity and interference of tobramycin and chloramphenicol on bacterial adhesion to intraocular lenses.
Drago L; De Vecchi E; Nicola L; Gismondo MR
Drugs Exp Clin Res; 2003; 29(1):25-35. PubMed ID: 12866361
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures.
Tré-Hardy M; Vanderbist F; Traore H; Devleeschouwer MJ
Int J Antimicrob Agents; 2008 Apr; 31(4):329-36. PubMed ID: 18280117
[TBL] [Abstract][Full Text] [Related]
3. Impact of slime dispersants and anti-adhesives on in vitro biofilm formation of Staphylococcus epidermidis on intraocular lenses and on antibiotic activities.
Kadry AA; Fouda SI; Shibl AM; Abu El-Asrar AA
J Antimicrob Chemother; 2009 Mar; 63(3):480-4. PubMed ID: 19147522
[TBL] [Abstract][Full Text] [Related]
4. In vitro study of antibiotic effect on bacterial adherence to acrylic intraocular lenses.
Gaál V; Kilár F; Acs B; Szijjártó Z; Kocsis B; Kustos I
Colloids Surf B Biointerfaces; 2005 Nov; 45(3-4):125-30. PubMed ID: 16199146
[TBL] [Abstract][Full Text] [Related]
5. Interaction between tobramycin and CSA-13 on clinical isolates of Pseudomonas aeruginosa in a model of young and mature biofilms.
Nagant C; Tré-Hardy M; El-Ouaaliti M; Savage P; Devleeschouwer M; Dehaye JP
Appl Microbiol Biotechnol; 2010 Sep; 88(1):251-63. PubMed ID: 20625718
[TBL] [Abstract][Full Text] [Related]
6. Liposomal bismuth-ethanedithiol formulation enhances antimicrobial activity of tobramycin.
Halwani M; Blomme S; Suntres ZE; Alipour M; Azghani AO; Kumar A; Omri A
Int J Pharm; 2008 Jun; 358(1-2):278-84. PubMed ID: 18448284
[TBL] [Abstract][Full Text] [Related]
7. Effect of aminoglycosides (sub-MICs) on adherence of coagulase-negative Staphylococci to intraocular lens surface.
Chisari G; Accossano S; Reibaldi M
J Chemother; 2002 Dec; 14(6):574-8. PubMed ID: 12583548
[TBL] [Abstract][Full Text] [Related]
8. In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae.
Lee MY; Ko KS; Song JH; Peck KR
J Antimicrob Chemother; 2007 Oct; 60(4):782-7. PubMed ID: 17681978
[TBL] [Abstract][Full Text] [Related]
9. Galangin expresses bactericidal activity against multiple-resistant bacteria: MRSA, Enterococcus spp. and Pseudomonas aeruginosa.
Pepeljnjak S; Kosalec I
FEMS Microbiol Lett; 2004 Nov; 240(1):111-6. PubMed ID: 15500987
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory efficacy of various antibiotics on matrix and viable mass of Staphylococcus aureus and Pseudomonas aeruginosa biofilms.
Toté K; Berghe DV; Deschacht M; de Wit K; Maes L; Cos P
Int J Antimicrob Agents; 2009 Jun; 33(6):525-31. PubMed ID: 19179053
[TBL] [Abstract][Full Text] [Related]
11. Effect of antibiotic co-administration on young and mature biofilms of cystic fibrosis clinical isolates: the importance of the biofilm model.
Tré-Hardy M; Macé C; El Manssouri N; Vanderbist F; Traore H; Devleeschouwer MJ
Int J Antimicrob Agents; 2009 Jan; 33(1):40-5. PubMed ID: 18801647
[TBL] [Abstract][Full Text] [Related]
12. Biofilm formation on hydrophilic intraocular lens material.
Shimizu K; Kobayakawa S; Tsuji A; Tochikubo T
Curr Eye Res; 2006 Dec; 31(12):989-97. PubMed ID: 17169836
[TBL] [Abstract][Full Text] [Related]
13. Effects of iron depletion on antimicrobial activities against planktonic and biofilm Pseudomonas aeruginosa.
Cai Y; Yu XH; Wang R; An MM; Liang BB
J Pharm Pharmacol; 2009 Sep; 61(9):1257-62. PubMed ID: 19703377
[TBL] [Abstract][Full Text] [Related]
14. Bismuth-thiol incorporation enhances biological activities of liposomal tobramycin against bacterial biofilm and quorum sensing molecules production by Pseudomonas aeruginosa.
Halwani M; Hebert S; Suntres ZE; Lafrenie RM; Azghani AO; Omri A
Int J Pharm; 2009 May; 373(1-2):141-6. PubMed ID: 19429299
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
[TBL] [Abstract][Full Text] [Related]
16. Subinhibitory concentrations of phenyl lactic acid interfere with the expression of virulence factors in Staphylococcus aureus and Pseudomonas aeruginosa clinical strains.
Chifiriuc MC; Diţu LM; Banu O; Bleotu C; Drăcea O; Bucur M; Larion C; Israil AM; Lazăr V
Roum Arch Microbiol Immunol; 2009; 68(1):27-33. PubMed ID: 19507624
[TBL] [Abstract][Full Text] [Related]
17. ['In vitro' activity of different antimicrobial agents on Gram-negative nonfermentative bacilli, excluding Pseudomonas aeruginosa and Acinetobacter spp].
Vay CA; Almuzara MN; Rodríguez CH; Pugliese ML; Lorenzo Barba F; Mattera JC; Famiglietti AM
Rev Argent Microbiol; 2005; 37(1):34-45. PubMed ID: 15991478
[TBL] [Abstract][Full Text] [Related]
18. Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY antimicrobial surveillance program (1999-2004).
Fritsche TR; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2007 May; 58(1):19-26. PubMed ID: 17383139
[TBL] [Abstract][Full Text] [Related]
19. [Ciprofloxacin in combination with other antimicrobial substances].
Shah PM; Mellinghoff D; Stille W
Arzneimittelforschung; 1988 Mar; 38(3):411-5. PubMed ID: 3164186
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
